全球荷爾蒙替代療法市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

預計到 2030 年，全球荷爾蒙替代療法市場的市場規模將從 2022 年的 236.8 億美元達到近 455.5 億美元，2023-2030 年研究期間複合年成長率為 8.52%。

荷爾蒙替代療法（HRT）是一種用於治療更年期問題的女性的療法。與人體正常生理所需的水平相比，此類患者的和諧水平不足。荷爾蒙替代療法可以改善並延長許多老年女性的壽命，無論是在更年期或更晚的時候開始。荷爾蒙替代療法可以幫助老年女性維持雌激素水平。

市場動態：

女性更年期不適的激增和對停經後問題認知的提高預計將在很大程度上影響荷爾蒙替代療法市場的成長。老年人口的成長是造成這種療法需求量大的另一個原因。同時，新的荷爾蒙替代療法產品的推出預計將推動市場成長。此外，藥物輸送系統的技術創新也可能對未來幾年的荷爾蒙替代療法市場產生正面影響。此外，人們對荷爾蒙替代療法認知的提高預計也將推動市場成長。然而，與荷爾蒙替代療法相關的高價格可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球荷爾蒙替代療法市場的每個細分市場進行了包容性評估。荷爾蒙替代療法產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲荷爾蒙替代療法市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。荷爾蒙替代療法市場的主要參與者包括拜耳公司、輝瑞公司、默克公司、Viatris公司、諾和諾德公司、禮來公司、羅氏公司、諾文製藥公司., ASCEND Therapeutics US LLC., AbbVie Inc.本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發射和其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：荷爾蒙替代療法 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按給藥途徑進行的市場吸引力分析
  • 按疾病類型分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球荷爾蒙替代療法市場分析：按產品

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 雌激素和黃體酮替代療法
• 人類生長激素 (HGH) 替代療法
• 甲狀腺激素替代療法
• 睾酮替代療法
• 副甲狀腺素替代療法

第 7 章：全球荷爾蒙替代療法市場分析：按給藥途徑

• 依給藥途徑概述
• 歷史和預測數據
• 依給藥途徑分析
• 口服
• 注射用
• 經皮
• 其他

第 8 章：全球荷爾蒙替代療法市場銷售分析：按疾病類型

• 依疾病類型概述
• 歷史和預測數據
• 依疾病類型分析
• 停經
• 甲狀腺功能低下症
• 男性性腺功能減退症
• 生長激素缺乏
• 副甲狀腺功能減退症

第 9 章：全球荷爾蒙替代療法市場銷售分析：按地理位置

• 區域展望銷售分析
• 簡介 銷售分析
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 10 章：荷爾蒙替代療法公司的競爭格局

• 荷爾蒙替代療法市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 11 章：公司簡介

• 十大公司股票分析
• 市場集中度
• Bayer AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Pfizer Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Merck & Co. Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Viatris Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Novo Nordisk A/S
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Eli Lilly and Company
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• F. Hoffmann-La Roche Ltd
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Noven Pharmaceuticals Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• ASCEND Therapeutics US LLC.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• AbbVie Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Hormone Replacement Therapy Market is presumed to reach the market size of nearly USD 45.55 BN by 2030 from USD 23.68 BN in 2022 with a CAGR of 8.52% under the study period 2023 - 2030.

Hormone replacement therapy (HRT) is a therapy used to treat women suffering from menopause issues. The harmones in such pateints are at inadequate levels compared to those required for the normal physiology of the human body. Hormone replacement therapy improves and extends the lives of many older women, whether initiated at menopause or much later. Hormone replacement therapy helps older women maintain their estrogen levels.

MARKET DYNAMICS:

A surge in menopausal discomfort and increased awareness about post-menopausal issues among women are expected to influence the hormone replacement therapy market growth to a great extent. The growth in the geriatric population is another reason for high demand of this therapy. Along with this, the launch of new hormone replacement therapy products is anticipated to drive market growth. Furthermore, the technological innovations in drug delivery systems could also positively impact the hormone replacement therapy market in the next few years. In addition, increased awareness about hormone replacement therapy is also expected to drive market growth. However, the high price associated with hormonal replacement therapy treatment may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hormone replacement therapy. The growth and trends of hormone replacement therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hormone replacement therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Estrogen And Progesterone Replacement Therapy
• Human Growth Hormone (HGH) Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Testosterone Replacement Therapy
• Parathyroid Hormone Replacement

By Route Of Administration

• Oral
• Parenteral
• Transdermal
• Others

By Disease Type

• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Hypoparathyroidism

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hormone Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hormone replacement therapy market include Bayer AG, Pfizer Inc., Merck & Co. Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Noven Pharmaceuticals Inc., ASCEND Therapeutics US LLC., AbbVie Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . HORMONE REPLACEMENT THERAPY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Route Of Administration
  • 3.7.3 Market Attractiveness Analysis By Disease Type
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Estrogen and Progesterone Replacement Therapy Historic and Forecast Sales by Regions
• 6.5 Human Growth Hormone (HGH) Replacement Therapy Historic and Forecast Sales by Regions
• 6.6 Thyroid Hormone Replacement Therapy Historic and Forecast Sales by Regions
• 6.7 Testosterone Replacement Therapy Historic and Forecast Sales by Regions
• 6.8 Parathyroid Hormone Replacement Historic and Forecast Sales by Regions

7 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route Of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route Of Administration
• 7.4 Oral Historic and Forecast Sales by Regions
• 7.5 Parenteral Historic and Forecast Sales by Regions
• 7.6 Transdermal Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY DISEASE TYPE

• 8.1 Overview by Disease Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Disease Type
• 8.4 Menopause Historic and Forecast Sales by Regions
• 8.5 Hypothyroidism Historic and Forecast Sales by Regions
• 8.6 Male Hypogonadism Historic and Forecast Sales by Regions
• 8.7 Growth Hormone Deficiency Historic and Forecast Sales by Regions
• 8.8 Hypoparathyroidism Historic and Forecast Sales by Regions

9 . GLOBAL HORMONE REPLACEMENT THERAPY MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HORMONE REPLACEMENT THERAPY COMPANIES

• 10.1. Hormone Replacement Therapy Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF HORMONE REPLACEMENT THERAPY INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Bayer AG
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Pfizer Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Merck & Co. Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Viatris Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Novo Nordisk A/S
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Eli Lilly and Company
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. F. Hoffmann-La Roche Ltd
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Noven Pharmaceuticals Inc.
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. ASCEND Therapeutics US LLC.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. AbbVie Inc.
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
• Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
• Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
• Testosterone Replacement Therapy Market Sales by Geography (USD MN)
• Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
• Analysis Market by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Transdermal Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by Disease Type (USD MN)
• Menopause Market Sales by Geography (USD MN)
• Hypothyroidism Market Sales by Geography (USD MN)
• Male Hypogonadism Market Sales by Geography (USD MN)
• Growth Hormone Deficiency Market Sales by Geography (USD MN)
• Hypoparathyroidism Market Sales by Geography (USD MN)
• Global Hormone Replacement Therapy Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Hormone Replacement Therapy Report
• Market Research Process
• Market Research Methodology
• Global Hormone Replacement Therapy Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Estrogen and Progesterone Replacement Therapy Market Sales by Geography (USD MN)
• Human Growth Hormone (HGH) Replacement Therapy Market Sales by Geography (USD MN)
• Thyroid Hormone Replacement Therapy Market Sales by Geography (USD MN)
• Testosterone Replacement Therapy Market Sales by Geography (USD MN)
• Parathyroid Hormone Replacement Market Sales by Geography (USD MN)
• Global Market Analysis by Route Of Administration (USD MN)
• Oral Market Sales by Geography (USD MN)
• Parenteral Market Sales by Geography (USD MN)
• Transdermal Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Disease Type (USD MN)
• Menopause Market Sales by Geography (USD MN)
• Hypothyroidism Market Sales by Geography (USD MN)
• Male Hypogonadism Market Sales by Geography (USD MN)
• Growth Hormone Deficiency Market Sales by Geography (USD MN)
• Hypoparathyroidism Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.